Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


Autism and Cord Blood Stem Cells: FDA Gives Green Light for Groundbreaking Clinical Trial 

 

 

Autism and Cord Blood Stem Cells: FDA Gives Green Light for Groundbreaking Clinical Trial

Aug. 21, 2012 - (Market Watch) - "Sutter Neuroscience Institute, a recognized Center of Excellence, and CBR (Cord Blood Registry), the world's largest stem cell bank, are launching the first FDA-approved clinical trial to assess the use of a child's own cord blood stem cells to treat select patients with autism. This first-of-its-kind placebo controlled study will evaluate the ability of an infusion of cord blood stem cells to help improve language and behavior. The study is in conjunction with the Sutter Institute for Medical Research."  Read Full Article

 

Posted on 23-Aug-12 by Toto, Brent
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: